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A strict relationship between allergic rhinitis and allergic asthma has been seen recently, and in many ways
respiratory allergy could be seen as a single disorder of the airways. The link between rhinitis and asthma can be
elucidated only by studying the natural history of the disease over long periods. We describe the follow-up of 99
allergic patients up to 10 years and the evolution of their disease. Ninety-nine patients (50 male, 49 female, mean
age 31 years) out of 142, suffering from allergic rhinitis or allergic asthma, could be monitored up to 10 years after
the initial diagnosis. Demographics, sensitizations and smoke habit were assumed as evaluation parameters. At
baseline, 44 patients suffered from AR alone, 12 from AA alone and 43 from AR+AA. After 10 years, 31?8% of
the AR patients developed developed AA and 50% of the patients with AA developed AR. Only the familial history
for atopy significantly influenced the disease’s evolution, whereas gender, age, smoking habit and skin sensitization
did not. Sixty-five percent of patients with a single sensitization at the beginning developed new sensitizations. In
conclusion, this long-term survey confirms that a relevant percentage of patients with AR alone or AA alone have a
progression of the disease.
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The overall pathogenic view of allergic respiratory diseases
has significantly changed during the last 10 years. It has
been realized that respiratory allergy cannot be considered
as confined to a single target organ (i.e. nose or bronchi),
but rather as a global disorder of the airways, which may
show various clinical expressions. In fact, a strict relation-
ship existing between upper and lower respiratory tract has
been seen (1,2). In this regard, several aspects should be
considered: the possible involvement of paranasal sinuses,
the presence of bronchial hyperreactivity in patients
suffering from allergic rhinitis alone (3) and the role of
viral respiratory infections (4). All these facts, taken
together, depict the concept of the ‘allergic rhinobronchi-
tis’. This aspect may have both pathophysiological and
therapeutic implications.
Indeed, the most valuable information on the links
existing between allergic rhinitis (AR) and allergic asthma
(AA) can be obtained only from the natural history of theReceived 28 March 2000 and accepted in revised form 1 August
2000. Published online 28 November 2000.
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concerning the evolution of upper respiratory allergy into
bronchial asthma and the association between AR and AA.
The reliability of these clinical data is directly correlated to
the length of the observation period considered (1). In the
present clinical study we studied the natural history of
respiratory allergy in a population of 99 allergic patients,
which could be followed-up up to 10 years after the initial
diagnosis. We also evaluated the possible influence of some
clinical and demographic parameters on the disease evolution.
Methods
We studied a population of allergic outpatients up to 10
years after the first visit and initial diagnosis (from 1986–
1987 to 1996–1997). During the period 1986–1987, more
than 500 patients were seen at our clinic with respiratory
complaints. A detailed diagnosis of respiratory allergy was
established in 142 patients (76 men and 66 women, mean
age 23?1 years). The remaining patients suffered from other
respiratory conditions [chronic obstructive pulmonary
disease (COPD), infectious diseases, vasomotor rhinitis]
and had no clinical or diagnostic evidence of atopy.
Patients underwent a detailed clinical history, examination
and skin testing. Skin tests were performed during the
whole period using commercial extracts (Lofarma SpA,# 2000 HARCOURT PUBLISHERS LTD
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Parietaria, olive, birch, hazelnut, ragweed, cat and dog
dander and Alternaria, plus a negative control and
histamine. The RAST assay was performed only in few
cases (discrepancy between clinical history and skin test or
negative histamine control). The diagnosis of AA was based
on the criteria established in 1986 by the American
Thoracic Society (5), which are essentially clinical ‘episodic
cough, wheezing and dyspnea’ either reported or actual.
The young age of patients virtually excluded the presence of
COPD. A non-specific bronchial challenge (with ultrasonic
fog) was performed in selected patients with normal
pulmonary function test. The diagnosis of rhinitis was
performed on a clinical basis: clinical history (at least 2
years) of perennial or seasonal itching, sneezing, rhinorrhea
and nasal blockage, in the absence of anatomical altera-
tions.
Each patient received an appropriate drug therapy for
the disease(s): oral anti-histamines, inhaled and nasal
corticosteroids, b2-agonists and oral theophylline were
prescribed. The treatments given at the first visit are
summarized in Table 1. Allergen avoidance measures were
suggested, when applicable. None of the patients was given
specific immunotherapy or leukotriene receptor antago-
nists.TABLE 1. Drug therapy prescribed at the first visit
Rhinitis (n=44) Oral antihistamine (n=31), nasal
corticosteroid (n=10), oral antihista-
mine+nasal corticosteroid (n=3)
Asthma (n=12) Inhaled albuterol (n=4), inhaled
albuterol+cromolyn (n=2), theo-
phylline (n=3), inhaled albuterol+
beclometasone (n=3)
Asthma+rhinitis
(n=43)
Oral antihistamine+inhaled albuter-
ol (n=28), anti-histamine+albuter-
ol+beclometasone (n=9), inhaled+
nasal beclometasone+theophylline
(n=3), all previous (n=3)
TABLE 2. Baseline (1986–87) demographics of the global popula
Global
population
Patients 99
Sex (M/F) 50/49
Mean age
Age range
22?6
14–37
Positive family history* 63
Smokers 27
Single sensitization 17
Two allergens 18
4Two allergens 64
*One or both relatives suffering from respiratory allergy.Results
Out of the initial 142 allergic patients, 43 dropped out
within 3 years because of refusal to perform further visits or
because they could not be found. Thus, we were able to
evaluate the remaining 99 patients. The baseline demo-
graphic data of the patients are shown in Table 2.
At baseline, 44 patients suffered from AR alone and 12
from AA alone; the remaining patients suffered from
AR+AA. The patients were homogeneously distributed
for gender and age (Table 2).
After 10 years, 31?8% of the AR patients had also
developed AA (mean onset time 5 years) and 50% of the
patients with AA had also developed AR (mean onset time
7 years). In contrast, no clinical change was seen in the 43
patients initially suffering from AR+AA (Table 3). At the
follow-up visit the severity of asthma was as follows: 5%
severe, 32% moderate, 41% mild-persistent and 22% mild-
intermittent. The most relevant factor influencing disease
evolution, as assessed by the w2-square test, seemed to be
the positive familial atopy history (one or both relatives
suffering from respiratory allergy). In fact 12 out of the 14
patients (86%) progressing to concomitant AA from AR
alone, and five out of six patients (83%) who also
developed AR from AA alone, had a positive family
history for atopy (Table 4). Gender, age and smoking habit
seemed not to play a relevant role. The number of skin
sensitizations at baseline did not significantly influence the
evolution of the disease, as shown in Table 4. The nature of
the allergens (perennial, seasonal or both) also did not
affect the natural history.
Noteworthy, 11 out of 17 (65%) patients with single
sensitization at baseline developed new sensitizations within
10 years. Finally, there was no spontaneous remission of
both asthma and rhinitis.
Discussion
The prevalence of AA and AR significantly varies among
different countries. The recent epidemiological ISAAC
study (2) conducted on about 500 000 adolescents reportedtion subdivided per disease
Rhinitis Asthma Rhinitis+
asthma
44 12 43
20/24 6/6 24/19
23?1
14–36
20?4
14–35
21?9
14–37
29 (66%) 9 (75%) 25 (58%)
9 (20%) 5 (42%) 13 (30%)
8 (18%) 3 (25%) 6 (14%)
7 (16%) 3 (25%) 8 (19%)
29 (66%) 6 (50%) 29 (67%)
TABLE 3. Evolution of the disease
At baseline After 10 years
Disease Patients Disease Patients % Evolved
Rhinitis and asthma 43 Rhinitis and asthma 43 0
Rhinitis alone 44 Rhinitis and asthma
Rhinitis alone
14
30
31?8
Asthma alone 12 Asthma and rhinitis
Asthma alone
6
6
50
Rhinitis or asthma 56 Rhinitis and asthma 20 36%
TABLE 4. Evolution depending on skin sensitizations and family history
1 or 2 skin positivities 4 2 skin positivities P value
w-square
R to R+A 5/14 36% 9/14 64% NS
A to A+R 3/6 50% 3/6 50% NS
Negative family history
for atopy
Positive family history
for atopy
R to R+A 2/14 14% 12/14 86% 0?01
A to A+R 1/6 17% 5/6 83% 0?01
R: rhinitis; A: asthma.
THE NATURAL HISTORY OF RESPIRATORY ALLERGY 11a prevalence ranging from 1?6 to 38% for asthma and from
1?4 to 39?7% for rhinitis. Noteworthy, a strict association
between AR and AA has become evident (for review see 6).
For instance, AR seems to precede or to accompany
AA in 59–85% of allergic patients in all age groups (7), and
AR is a risk factor for developing asthma (1,8). Moreover,
in a recent work conducted with rigorous criteria it
was shown that about 90% of allergic asthmatics also
have rhinitis (9). The link existing between upper and
lower respiratory allergy suggest the hypothesis of the
allergic rhinobronchitis or united airways disease, meaning
that respiratory allergy is an unique disorder varying its
clinical expression from rhinitis to asthma. Indeed, the
possible evolution from bronchial or nasal symptoms into
each other can be observed only by means of long-term
studies.
The results herein reported, obtained from a 10-year
follow-up of selected patients, confirm the presently
available data: a relevant part (31?8%) of patients with
AR developed AA and 50% of patients with AA developed
AR. The data come from a homogeneous population, since
only patients with clinical evidence of atopy were included.
Indeed, the long period of observation itself imposes some
limitations to our study. For instance, the criteria for AA
and AR have partly changed over the 10-year period
considered herein. Moreover, the criteria used in 1986 did
not include a severity staging. Nevertheless, the mainclinical criteria for diagnosing rhinitis and asthma have
remained approximately the same, as has the skin test for
ascertaining allergic sensitizations. Data on non-specific
bronchial hyperresponsiveness are not provided because, at
the time of the first diagnosis we used the ultrasonic fog
test, which was subsequently abandoned in favour of the
methacholine test. Finally, we have no information about
the presence of non-specific bronchial hyperresponsiveness
in rhinitics, since at the time of the first diagnosis, this was
not considered relevant. The sample studied is relatively
small, certainly because of the very long period of
observation, therefore it is dicult to properly identify
‘risk factors’; on the other hand, it is possible to state that
positive familial history influences the evolution of the
disease.
However, the high rate of progression of AR towards AA
and vice versa is further confirmed on a merely clinical
basis; this simple fact has potential important implications.
In fact, an appropriate diagnosis and survey of allergic
patients may lead to a better treatment approach and to a
significant socioeconomic saving, when costs of asthma are
considered (10). Moreover, the epidemiological data taken
together with the experimental evidence would envisage the
realistic possibility of improving the treatment strategy of
respiratory allergy: an optimal control of rhinitis may
also improve asthma symptoms (11) or prevent their
onset (12).
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